Skip to content

Clinical characteristics of primary aldosteronism

Clinical characteristics of primary aldosteronism - Clinical characteristics of primary aldosteronism

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000022470
Enrollment
200
Registered
2025-01-01
Start date
2016-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary aldosteronism Essential hypertension

Interventions

None listed

Sponsors

Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with primary aldosteronism and performed adrenal venous sampling. (January, 2015-January, 2025).

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
Circadian variation of adrenocortical hormones 24-h Urinary Aldosterone Visceral fat tissue Subcutaneous fat tissue Subtype of primary aldosteronism

Countries

Japan

Contacts

Public ContactHaketa Akira

Nihon University School of Medicine Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine

haketa.akira@nihon-u.ac.jp+81-3-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026